Takeda Pharmaceutical Co. Ltd. 3% 18/30

Takeda Pharmaceutical Co. Ltd. 3% 18/30Japan

96.23%
Current yield
3.12%
Coupon p.a.
3.00%
Yield to maturity
4.01%
Ex-DatePay DateCoupon
3.00%
3.00%
3.00%
3.00%
7 more years of interest dates, back to 2019.Sign up for free

Takeda Pharmaceutical Co. Ltd. 3% 18/30 has a current yield of 3.12%.

ISIN
WKN
Exchange
XFRA
Value
96.23%
Interest schedule
annually
Security Type
Bond
Sector

-

Country
Japan

Japan

Maturity
Interest currency
Euro

ETFs holding Takeda Pharmaceutical Co. Ltd. 3% 18/30

9 ETFs invest at least 1% in Takeda Pharmaceutical Co. Ltd. 3% 18/30.

SecurityWeightPopularityDiv.%Div.CAGR 5YDiv.Freq.
ERSTE Responsible Bond EUR R01 A
2.07%15,6582.06%#.##%annually
ERSTE Responsible Bond Euro Corporate EUR R01 A
1.02%17,3632.59%#.##%annually
LLB Obligationen EUR Kl. T
LLB Obligationen EUR Kl. T
1.19%19,861-#.##%none

Access all 9 ETFs?Exclusive feature for our aristocrats.

Frequently Asked Questions about Takeda Pharmaceutical Co. Ltd. 3% 18/30

Over the last 12 months Takeda Pharmaceutical Co. Ltd. 3% 18/30 paid interest of 3.00% of nominal. For the coming 12 months 3.00% is expected, which is a current yield of about 3.12%.
The current yield of Takeda Pharmaceutical Co. Ltd. 3% 18/30 is 3.12%. It sets the coupon against today's price and is not the yield to maturity.
At the current price the yield to maturity of Takeda Pharmaceutical Co. Ltd. 3% 18/30 is 4.01% p.a. It assumes you hold the bond until 21 November 2030, that every coupon is paid as scheduled and that the nominal is repaid in full at the end.
Takeda Pharmaceutical Co. Ltd. 3% 18/30 pays interest once a year. The interest date falls in November.
The next interest payment is due on 21 November 2026.
Takeda Pharmaceutical Co. Ltd. 3% 18/30 matures on 21 November 2030. That is the day the nominal is repaid.
The last interest payment was made on 21 November 2025.
In 2025 interest of 3.00% of nominal was paid.
The interest of Takeda Pharmaceutical Co. Ltd. 3% 18/30 is paid in Euro.
The issuer of Takeda Pharmaceutical Co. Ltd. 3% 18/30 is from Japan.